Attention AACR-NCI-EORTC Molecular Targets Conference Registrants - Activate Your Access

Login for full access:

Username and password are not your MyAACR account information

Search:

Search for text in:

separate each search
term with a space

Multiple terms:

Additional Search Filters:

Conference Years:

Days Within Meeting:

Conferences:

Availability:

Participation Type:

Presentations Access:

Presentation Access:

Topic Tracks*:

Organ Site Tracks*:

Anti-Ras Drug Discovery: Mission Impossible?

  • Sort by:
  • Browse by:
<< first | < prev page: of 1 records per page: next > | last >>
pages: 1 presentations: 1 to 4 of 4
New targets on the KRAS pathway
Frank McCormick
UCSF Helen Diller Family Comp. Cancer Ctr., San Francisco, CA, United States
from AACR Annual Meeting 2014 on April 5, 2014 1:00 PM-3:00 PM
Targeting ERK effector signaling for the treatment of KRAS mutant pancreaticcancer
Channing J. Der
UNC Lineberger Comp. Cancer Ctr., Chapel Hill, NC, United States
from AACR Annual Meeting 2014 on April 5, 2014 1:00 PM-3:00 PM
Targeting oncogenic Ras: One size doesn’t fit all
Dafna Bar-Sagi
New York Univ. Langone Medical Ctr., New York, NY, United States
from AACR Annual Meeting 2014 on April 5, 2014 1:00 PM-3:00 PM
Exploiting fragility in oncogenic Ras signaling networks
Michael A. White
UT Southwestern Medical Ctr., Dallas, TX, United States
from AACR Annual Meeting 2014 on April 5, 2014 1:00 PM-3:00 PM
<< first | < prev page: of 1 records per page: next > | last >>
pages: 1 presentations: 1 to 4 of 4